A library of fully synthetic analogs of (−)-FR252921 was designed to map its structure-activity relationship, revealing key molecular features that influence its immunosuppressive potency. This enabled the discovery of fs-FR4, a new lead compound with up to 21-fold higher potency than the natural product, while also improving synthetic efficiency for future drug development.
Read more about it here: Publication (open access)
and here (German) and here (English)
